# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021883
Filing Date
2022-11-03
Accepted
2022-11-03 16:15:50
Documents
82
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dvax-20220930.htm iXBRL | 10-Q | 4656708
2 | EX-10.1 | dvax-ex10_1.htm | EX-10.1 | 36341
3 | EX-10.2 | dvax-ex10_2.htm | EX-10.2 | 113649
4 | EX-10.3 | dvax-ex10_3.htm | EX-10.3 | 44471
5 | EX-10.4 | dvax-ex10_4.htm | EX-10.4 | 54363
6 | EX-31.1 | dvax-ex31_1.htm | EX-31.1 | 18245
7 | EX-31.2 | dvax-ex31_2.htm | EX-31.2 | 17900
8 | EX-32.1 | dvax-ex32_1.htm | EX-32.1 | 11391
9 | EX-32.2 | dvax-ex32_2.htm | EX-32.2 | 11850
| Complete submission text file | 0000950170-22-021883.txt |  | 16055402

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | dvax-20220930_cal.xml | EX-101.CAL | 65260
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | dvax-20220930_pre.xml | EX-101.PRE | 489744
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | dvax-20220930_def.xml | EX-101.DEF | 332444
13 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | dvax-20220930.xsd | EX-101.SCH | 81771
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | dvax-20220930_lab.xml | EX-101.LAB | 635806
76 | EXTRACTED XBRL INSTANCE DOCUMENT | dvax-20220930_htm.xml | XML | 3549794

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 221358223
SIC: 2834 Pharmaceutical Preparations